Bank of New York Mellon Corp Has $5.95 Million Stock Position in Summit Therapeutics Inc. (NASDAQ:SMMT)
Bank of New York Mellon Corp increased its position in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 33.7% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 333,510 shares of the company’s stock after purchasing an additional 84,117 shares during […]
